Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

Clinical trial NCT03870750 · TERMINATED

Trial details

NCT number: NCT03870750
Sponsor: Fred Hutchinson Cancer Center
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hematopoietic and Lymphoid Cell Neoplasm Non-Neoplastic Hematologic and Lymphocytic Disorder

Start date: 2019-08-15
Primary completion: 2025-12-31
Enrollment: 458

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.